Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 567

1.

Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.

Ribas A, Lawrence D, Atkinson V, Agarwal S, Miller WH Jr, Carlino MS, Fisher R, Long GV, Hodi FS, Tsoi J, Grasso CS, Mookerjee B, Zhao Q, Ghori R, Moreno BH, Ibrahim N, Hamid O.

Nat Med. 2019 Aug;25(8):1319. doi: 10.1038/s41591-019-0535-y.

PMID:
31267021
2.

A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy.

Kumar R, de Vijver MV, Tortora G, Ciardiello F, Goldkorn T, Miller WH Jr, Norton L.

Cancer Res. 2019 Sep 1;79(17):4315-4323. doi: 10.1158/0008-5472.CAN-19-0989. Epub 2019 Jun 18. Review.

PMID:
31213466
3.

Translation of cancer immunotherapy from the bench to the bedside.

Guo Q, Huang F, Goncalves C, Del Rincón SV, Miller WH Jr.

Adv Cancer Res. 2019;143:1-62. doi: 10.1016/bs.acr.2019.03.001. Epub 2019 May 2.

PMID:
31202357
4.

Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy.

Esfahani K, Buhlaiga N, Thébault P, Lapointe R, Johnson NA, Miller WH Jr.

N Engl J Med. 2019 Jun 13;380(24):2375-2376. doi: 10.1056/NEJMc1903064. No abstract available.

PMID:
31189042
5.

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.

Ribas A, Lawrence D, Atkinson V, Agarwal S, Miller WH Jr, Carlino MS, Fisher R, Long GV, Hodi FS, Tsoi J, Grasso CS, Mookerjee B, Zhao Q, Ghori R, Moreno BH, Ibrahim N, Hamid O.

Nat Med. 2019 Jun;25(6):936-940. doi: 10.1038/s41591-019-0476-5. Epub 2019 Jun 6. Erratum in: Nat Med. 2019 Aug;25(8):1319.

PMID:
31171879
6.

Verification of I-131Yields from the neutron irradiation of tellurium.

Haffner R, Miller WH, Morris S.

Appl Radiat Isot. 2019 Sep;151:52-61. doi: 10.1016/j.apradiso.2019.05.001. Epub 2019 May 3.

PMID:
31158706
7.
8.

External ear cytological results and resident flora of clinically normal alpacas (Vicugna pacos).

Mazulis CA, Erb HN, Thachil A, Miller WH Jr.

Vet Dermatol. 2019 Aug;30(4):337-e94. doi: 10.1111/vde.12751. Epub 2019 Apr 30.

PMID:
31038257
9.

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.

Rodon J, Soria JC, Berger R, Miller WH, Rubin E, Kugel A, Tsimberidou A, Saintigny P, Ackerstein A, Braña I, Loriot Y, Afshar M, Miller V, Wunder F, Bresson C, Martini JF, Raynaud J, Mendelsohn J, Batist G, Onn A, Tabernero J, Schilsky RL, Lazar V, Lee JJ, Kurzrock R.

Nat Med. 2019 May;25(5):751-758. doi: 10.1038/s41591-019-0424-4. Epub 2019 Apr 22.

PMID:
31011205
10.

Search for Sterile Neutrinos in MINOS and MINOS+ Using a Two-Detector Fit.

Adamson P, Anghel I, Aurisano A, Barr G, Bishai M, Blake A, Bock GJ, Bogert D, Cao SV, Carroll TJ, Castromonte CM, Chen R, Childress S, Coelho JAB, Corwin L, Cronin-Hennessy D, de Jong JK, De Rijck S, Devan AV, Devenish NE, Diwan MV, Escobar CO, Evans JJ, Falk E, Feldman GJ, Flanagan W, Frohne MV, Gabrielyan M, Gallagher HR, Germani S, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hahn SR, Hartnell J, Hatcher R, Holin A, Huang J, Hylen J, Irwin GM, Isvan Z, James C, Jensen D, Kafka T, Kasahara SMS, Koerner LW, Koizumi G, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield PJ, Lucas P, Mann WA, Marshak ML, Mayer N, McGivern C, Medeiros MM, Mehdiyev R, Meier JR, Messier MD, Miller WH, Mishra SR, Moed Sher S, Moore CD, Mualem L, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, O'Connor J, Orchanian M, Pahlka RB, Paley J, Patterson RB, Pawloski G, Perch A, Pfützner MM, Phan DD, Phan-Budd S, Plunkett RK, Poonthottathil N, Qiu X, Radovic A, Rebel B, Rosenfeld C, Rubin HA, Sail P, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga RL, Thomas J, Thomson MA, Tian X, Timmons A, Todd J, Tognini SC, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead LH, Wojcicki SG, Zwaska R; MINOS+ Collaboration.

Phys Rev Lett. 2019 Mar 8;122(9):091803. doi: 10.1103/PhysRevLett.122.091803.

PMID:
30932529
11.

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors.

Hellmann MD, Kim TW, Lee CB, Goh BC, Miller WH, Oh DY, Jamal R, Chee CE, Chow LQM, Gainor JF, Desai J, Solomon BJ, Das Thakur M, Pitcher B, Foster P, Hernandez G, Wongchenko MJ, Cha E, Bang YJ, Siu LL, Bendell J.

Ann Oncol. 2019 Jul 1;30(7):1134-1142. doi: 10.1093/annonc/mdz113.

PMID:
30918950
12.
13.

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT, Venugopal B, Kollmannsberger C, Negrier S, Uemura M, Lee JL, Vasiliev A, Miller WH Jr, Gurney H, Schmidinger M, Larkin J, Atkins MB, Bedke J, Alekseev B, Wang J, Mariani M, Robbins PB, Chudnovsky A, Fowst C, Hariharan S, Huang B, di Pietro A, Choueiri TK.

N Engl J Med. 2019 Mar 21;380(12):1103-1115. doi: 10.1056/NEJMoa1816047. Epub 2019 Feb 16.

14.

MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.

Guo Q, Li VZ, Nichol JN, Huang F, Yang W, Preston SEJ, Talat Z, Lefrère H, Yu H, Zhang G, Basik M, Gonçalves C, Zhan Y, Plourde D, Su J, Torres J, Marques M, Habyan SA, Bijian K, Amant F, Witcher M, Behbod F, McCaffrey L, Alaoui-Jamali M, Giannakopoulos NV, Brackstone M, Postovit LM, Del Rincón SV, Miller WH Jr.

Cancer Res. 2019 Apr 1;79(7):1646-1657. doi: 10.1158/0008-5472.CAN-18-1602. Epub 2019 Jan 18.

15.

Adverse events associated with immune checkpoint inhibitor treatment for cancer.

Esfahani K, Meti N, Miller WH Jr, Hudson M.

CMAJ. 2019 Jan 14;191(2):E40-E46. doi: 10.1503/cmaj.180870. Review. No abstract available.

PMID:
30642824
16.

The symmetrical quasi-classical approach to electronically nonadiabatic dynamics applied to ultrafast exciton migration processes in semiconducting polymers.

Liang R, Cotton SJ, Binder R, Hegger R, Burghardt I, Miller WH.

J Chem Phys. 2018 Jul 28;149(4):044101. doi: 10.1063/1.5037815.

PMID:
30068189
17.

Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils.

Robichaud N, Hsu BE, Istomine R, Alvarez F, Blagih J, Ma EH, Morales SV, Dai DL, Li G, Souleimanova M, Guo Q, Del Rincon SV, Miller WH Jr, Ramón Y Cajal S, Park M, Jones RG, Piccirillo CA, Siegel PM, Sonenberg N.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2202-E2209. doi: 10.1073/pnas.1717439115. Epub 2018 Feb 20.

18.

Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection.

Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri-Shirvani J, Derakhshan MH.

Aliment Pharmacol Ther. 2018 Apr;47(7):868-876. doi: 10.1111/apt.14561. Epub 2018 Feb 12.

19.

Beta Skin Dosimetry using Passivated Planar Silicon Detector.

Tchouaso MT, Miller WH.

Appl Radiat Isot. 2018 May;135:99-103. doi: 10.1016/j.apradiso.2018.01.026. Epub 2018 Jan 31.

PMID:
29413843
20.

Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma.

Jamal R, Lapointe R, Cocolakis E, Thébault P, Kazemi S, Friedmann JE, Dionne J, Cailhier JF, Bélanger K, Ayoub JP, Le H, Lambert C, El-Hajjar J, van Kempen LC, Spatz A, Miller WH Jr.

J Immunother Cancer. 2017 Nov 21;5(1):83. doi: 10.1186/s40425-017-0290-x.

21.

The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity.

Zahreddine HA, Culjkovic-Kraljacic B, Emond A, Pettersson F, Midura R, Lauer M, Del Rincon S, Cali V, Assouline S, Miller WH, Hascall V, Borden KL.

Elife. 2017 Nov 7;6. pii: e29830. doi: 10.7554/eLife.29830.

22.

MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.

Zhan Y, Guo J, Yang W, Goncalves C, Rzymski T, Dreas A, Żyłkiewicz E, Mikulski M, Brzózka K, Golas A, Kong Y, Ma M, Huang F, Huor B, Guo Q, da Silva SD, Torres J, Cai Y, Topisirovic I, Su J, Bijian K, Alaoui-Jamali MA, Huang S, Journe F, Ghanem GE, Miller WH Jr, Del Rincón SV.

J Clin Invest. 2017 Nov 1;127(11):4179-4192. doi: 10.1172/JCI91258. Epub 2017 Oct 16.

23.

Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.

Petrella TM, Robert C, Richtig E, Miller WH Jr, Masucci GV, Walpole E, Lebbe C, Steven N, Middleton MR, Hille D, Zhou W, Ibrahim N, Cebon J.

Eur J Cancer. 2017 Nov;86:115-124. doi: 10.1016/j.ejca.2017.08.032. Epub 2017 Oct 4.

24.

On the adiabatic representation of Meyer-Miller electronic-nuclear dynamics.

Cotton SJ, Liang R, Miller WH.

J Chem Phys. 2017 Aug 14;147(6):064112. doi: 10.1063/1.4995301.

PMID:
28810754
25.

Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis.

Dahabieh MS, Ha Z, Di Pietro E, Nichol JN, Bolt AM, Goncalves C, Dupéré-Richer D, Pettersson F, Mann KK, Braverman NE, Del Rincón SV, Miller WH Jr.

Cell Death Differ. 2017 Nov;24(11):1912-1924. doi: 10.1038/cdd.2017.115. Epub 2017 Jul 21.

26.

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.

Larkin J, Minor D, D'Angelo S, Neyns B, Smylie M, Miller WH Jr, Gutzmer R, Linette G, Chmielowski B, Lao CD, Lorigan P, Grossmann K, Hassel JC, Sznol M, Daud A, Sosman J, Khushalani N, Schadendorf D, Hoeller C, Walker D, Kong G, Horak C, Weber J.

J Clin Oncol. 2018 Feb 1;36(4):383-390. doi: 10.1200/JCO.2016.71.8023. Epub 2017 Jul 3.

PMID:
28671856
27.

Constraints on Oscillation Parameters from ν_{e} Appearance and ν_{μ} Disappearance in NOvA.

Adamson P, Aliaga L, Ambrose D, Anfimov N, Antoshkin A, Arrieta-Diaz E, Augsten K, Aurisano A, Backhouse C, Baird M, Bambah BA, Bays K, Behera B, Bending S, Bernstein R, Bhatnagar V, Bhuyan B, Bian J, Blackburn T, Bolshakova A, Bromberg C, Brown J, Brunetti G, Buchanan N, Butkevich A, Bychkov V, Campbell M, Catano-Mur E, Childress S, Choudhary BC, Chowdhury B, Coan TE, Coelho JAB, Colo M, Cooper J, Corwin L, Cremonesi L, Cronin-Hennessy D, Davies GS, Davies JP, Derwent PF, Dharmapalan R, Ding P, Djurcic Z, Dukes EC, Duyang H, Edayath S, Ehrlich R, Feldman GJ, Frank MJ, Gabrielyan M, Gallagher HR, Germani S, Ghosh T, Giri A, Gomes RA, Goodman MC, Grichine V, Group R, Grover D, Guo B, Habig A, Hartnell J, Hatcher R, Hatzikoutelis A, Heller K, Himmel A, Holin A, Hylen J, Jediny F, Judah M, Kafka GK, Kalra D, Kasahara SMS, Kasetti S, Keloth R, Kolupaeva L, Kotelnikov S, Kourbanis I, Kreymer A, Kumar A, Kurbanov S, Lang K, Lee WM, Lin S, Liu J, Lokajicek M, Lozier J, Luchuk S, Maan K, Magill S, Mann WA, Marshak ML, Matera K, Matveev V, Méndez DP, Messier MD, Meyer H, Miao T, Miller WH, Mishra SR, Mohanta R, Moren A, Mualem L, Muether M, Mufson S, Murphy R, Musser J, Nelson JK, Nichol R, Niner E, Norman A, Nosek T, Oksuzian Y, Olshevskiy A, Olson T, Paley J, Pandey P, Patterson RB, Pawloski G, Pershey D, Petrova O, Petti R, Phan-Budd S, Plunkett RK, Poling R, Potukuchi B, Principato C, Psihas F, Radovic A, Rameika RA, Rebel B, Reed B, Rocco D, Rojas P, Ryabov V, Sachdev K, Sail P, Samoylov O, Sanchez MC, Schroeter R, Sepulveda-Quiroz J, Shanahan P, Sheshukov A, Singh J, Singh J, Singh P, Singh V, Smolik J, Solomey N, Song E, Sousa A, Soustruznik K, Strait M, Suter L, Talaga RL, Tamsett MC, Tas P, Thayyullathil RB, Thomas J, Tian X, Tognini SC, Tripathi J, Tsaris A, Urheim J, Vahle P, Vasel J, Vinton L, Vold A, Vrba T, Wang B, Wetstein M, Whittington D, Wojcicki SG, Wolcott J, Yadav N, Yang S, Zalesak J, Zamorano B, Zwaska R; NOvA Collaboration.

Phys Rev Lett. 2017 Jun 9;118(23):231801. doi: 10.1103/PhysRevLett.118.231801. Epub 2017 Jun 5.

PMID:
28644674
28.

Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade.

Esfahani K, Miller WH Jr.

N Engl J Med. 2017 May 18;376(20):1989-91. doi: 10.1056/NEJMc1703047. No abstract available.

PMID:
28514612
29.

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.

Blank CU, Larkin J, Arance AM, Hauschild A, Queirolo P, Del Vecchio M, Ascierto PA, Krajsova I, Schachter J, Neyns B, Garbe C, Chiarion Sileni V, Mandalà M, Gogas H, Espinosa E, Hospers GAP, Miller WH Jr, Robson S, Makrutzki M, Antic V, Brown MP.

Eur J Cancer. 2017 Jul;79:176-184. doi: 10.1016/j.ejca.2017.04.007. Epub 2017 May 11.

PMID:
28501764
30.

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.

Chia SK, Ellard SL, Mates M, Welch S, Mihalcioiu C, Miller WH Jr, Gelmon K, Lohrisch C, Kumar V, Taylor S, Hagerman L, Goodwin R, Wang T, Sakashita S, Tsao MS, Eisenhauer E, Bradbury P.

Breast Cancer Res. 2017 May 2;19(1):54. doi: 10.1186/s13058-017-0836-3.

31.

Measurement of the Neutrino Mixing Angle θ_{23} in NOvA.

Adamson P, Aliaga L, Ambrose D, Anfimov N, Antoshkin A, Arrieta-Diaz E, Augsten K, Aurisano A, Backhouse C, Baird M, Bambah BA, Bays K, Behera B, Bending S, Bernstein R, Bhatnagar V, Bhuyan B, Bian J, Blackburn T, Bolshakova A, Bromberg C, Brown J, Brunetti G, Buchanan N, Butkevich A, Bychkov V, Campbell M, Catano-Mur E, Childress S, Choudhary BC, Chowdhury B, Coan TE, Coelho JAB, Colo M, Cooper J, Corwin L, Cremonesi L, Cronin-Hennessy D, Davies GS, Davies JP, Derwent PF, Desai S, Dharmapalan R, Ding P, Djurcic Z, Dukes EC, Duyang H, Edayath S, Ehrlich R, Feldman GJ, Frank MJ, Gabrielyan M, Gallagher HR, Germani S, Ghosh T, Giri A, Gomes RA, Goodman MC, Grichine V, Group R, Grover D, Guo B, Habig A, Hartnell J, Hatcher R, Hatzikoutelis A, Heller K, Himmel A, Holin A, Hylen J, Jediny F, Judah M, Kafka GK, Kalra D, Kasahara SMS, Kasetti S, Keloth R, Kolupaeva L, Kotelnikov S, Kourbanis I, Kreymer A, Kumar A, Kurbanov S, Lang K, Lee WM, Lin S, Liu J, Lokajicek M, Lozier J, Luchuk S, Maan K, Magill S, Mann WA, Marshak ML, Matera K, Matveev V, Méndez DP, Messier MD, Meyer H, Miao T, Miller WH, Mishra SR, Mohanta R, Moren A, Mualem L, Muether M, Mufson S, Murphy R, Musser J, Nelson JK, Nichol R, Niner E, Norman A, Nosek T, Oksuzian Y, Olshevskiy A, Olson T, Paley J, Pandey P, Patterson RB, Pawloski G, Pershey D, Petrova O, Petti R, Phan-Budd S, Plunkett RK, Poling R, Potukuchi B, Principato C, Psihas F, Radovic A, Rameika RA, Rebel B, Reed B, Rocco D, Rojas P, Ryabov V, Sachdev K, Sail P, Samoylov O, Sanchez MC, Schroeter R, Sepulveda-Quiroz J, Shanahan P, Sheshukov A, Singh J, Singh J, Singh P, Singh V, Smolik J, Solomey N, Song E, Sousa A, Soustruznik K, Strait M, Suter L, Talaga RL, Tamsett MC, Tas P, Thayyullathil RB, Thomas J, Tian X, Tognini SC, Tripathi J, Tsaris A, Urheim J, Vahle P, Vasel J, Vinton L, Vold A, Vrba T, Wang B, Wetstein M, Whittington D, Wojcicki SG, Wolcott J, Yadav N, Yang S, Zalesak J, Zamorano B, Zwaska R; NOvA Collaboration.

Phys Rev Lett. 2017 Apr 14;118(15):151802. doi: 10.1103/PhysRevLett.118.151802. Epub 2017 Apr 10.

PMID:
28452513
32.

Endosomal sorting and c-Cbl targeting of paxillin to autophagosomes regulate cell-matrix adhesion turnover in human breast cancer cells.

Chang CH, Bijian K, Qiu D, Su J, Saad A, Dahabieh MS, Miller WH Jr, Alaoui-Jamali MA.

Oncotarget. 2017 May 9;8(19):31199-31214. doi: 10.18632/oncotarget.16105.

33.

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.

D'Angelo SP, Larkin J, Sosman JA, Lebbé C, Brady B, Neyns B, Schmidt H, Hassel JC, Hodi FS, Lorigan P, Savage KJ, Miller WH Jr, Mohr P, Marquez-Rodas I, Charles J, Kaatz M, Sznol M, Weber JS, Shoushtari AN, Ruisi M, Jiang J, Wolchok JD.

J Clin Oncol. 2017 Jan 10;35(2):226-235. Epub 2016 Nov 7.

34.

Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer.

Ferrario C, Strepponi I, Esfahani K, Charamis H, Langleben A, Scarpi E, Nanni O, Miller WH Jr, Panasci LC.

PLoS One. 2016 Dec 19;11(12):e0167906. doi: 10.1371/journal.pone.0167906. eCollection 2016.

35.

Fundamentals: general discussion.

Althorpe SC, Beniwal V, Bolhuis PG, Brandão J, Clary DC, Ellis J, Fang W, Glowacki DR, Hele TJ, Jónsson H, Kästner J, Makri N, Manolopoulos DE, McKemmish LK, Menzl G, Miller TF III, Miller WH, Pollak E, Rampino S, Richardson JO, Richter M, Roy Chowdhury P, Shalashilin D, Tennyson J, Welsch R.

Faraday Discuss. 2016 Dec 22;195:139-169. doi: 10.1039/c6fd90077a. No abstract available.

PMID:
27942654
36.

Non-adiabatic reactions: general discussion.

Althorpe SC, Ananth N, Angulo G, Astumian RD, Beniwal V, Blumberger J, Bolhuis PG, Ensing B, Glowacki DR, Habershon S, Hammes-Schiffer S, Hele TJ, Makri N, Manolopoulos DE, McKemmish LK, Miller TF III, Miller WH, Mulholland AJ, Nekipelova T, Pollak E, Richardson JO, Richter M, Roy Chowdhury P, Shalashilin D, Szabla R.

Faraday Discuss. 2016 Dec 22;195:311-344. doi: 10.1039/c6fd90078j. No abstract available.

PMID:
27929583
37.

Classical molecular dynamics simulation of electronically non-adiabatic processes.

Miller WH, Cotton SJ.

Faraday Discuss. 2016 Dec 22;195:9-30. doi: 10.1039/c6fd00181e.

PMID:
27828549
39.

Limits on Active to Sterile Neutrino Oscillations from Disappearance Searches in the MINOS, Daya Bay, and Bugey-3 Experiments.

Adamson P, An FP, Anghel I, Aurisano A, Balantekin AB, Band HR, Barr G, Bishai M, Blake A, Blyth S, Bock GJ, Bogert D, Cao D, Cao GF, Cao J, Cao SV, Carroll TJ, Castromonte CM, Cen WR, Chan YL, Chang JF, Chang LC, Chang Y, Chen HS, Chen QY, Chen R, Chen SM, Chen Y, Chen YX, Cheng J, Cheng JH, Cheng YP, Cheng ZK, Cherwinka JJ, Childress S, Chu MC, Chukanov A, Coelho JA, Corwin L, Cronin-Hennessy D, Cummings JP, de Arcos J, De Rijck S, Deng ZY, Devan AV, Devenish NE, Ding XF, Ding YY, Diwan MV, Dolgareva M, Dove J, Dwyer DA, Edwards WR, Escobar CO, Evans JJ, Falk E, Feldman GJ, Flanagan W, Frohne MV, Gabrielyan M, Gallagher HR, Germani S, Gill R, Gomes RA, Gonchar M, Gong GH, Gong H, Goodman MC, Gouffon P, Graf N, Gran R, Grassi M, Grzelak K, Gu WQ, Guan MY, Guo L, Guo RP, Guo XH, Guo Z, Habig A, Hackenburg RW, Hahn SR, Han R, Hans S, Hartnell J, Hatcher R, He M, Heeger KM, Heng YK, Higuera A, Holin A, Hor YK, Hsiung YB, Hu BZ, Hu T, Hu W, Huang EC, Huang HX, Huang J, Huang XT, Huber P, Huo W, Hussain G, Hylen J, Irwin GM, Isvan Z, Jaffe DE, Jaffke P, James C, Jen KL, Jensen D, Jetter S, Ji XL, Ji XP, Jiao JB, Johnson RA, de Jong JK, Joshi J, Kafka T, Kang L, Kasahara SM, Kettell SH, Kohn S, Koizumi G, Kordosky M, Kramer M, Kreymer A, Kwan KK, Kwok MW, Kwok T, Lang K, Langford TJ, Lau K, Lebanowski L, Lee J, Lee JH, Lei RT, Leitner R, Leung JK, Li C, Li DJ, Li F, Li GS, Li QJ, Li S, Li SC, Li WD, Li XN, Li YF, Li ZB, Liang H, Lin CJ, Lin GL, Lin S, Lin SK, Lin YC, Ling JJ, Link JM, Litchfield PJ, Littenberg L, Littlejohn BR, Liu DW, Liu JC, Liu JL, Loh CW, Lu C, Lu HQ, Lu JS, Lucas P, Luk KB, Lv Z, Ma QM, Ma XB, Ma XY, Ma YQ, Malyshkin Y, Mann WA, Marshak ML, Martinez Caicedo DA, Mayer N, McDonald KT, McGivern C, McKeown RD, Medeiros MM, Mehdiyev R, Meier JR, Messier MD, Miller WH, Mishra SR, Mitchell I, Mooney M, Moore CD, Mualem L, Musser J, Nakajima Y, Naples D, Napolitano J, Naumov D, Naumova E, Nelson JK, Newman HB, Ngai HY, Nichol RJ, Ning Z, Nowak JA, O'Connor J, Ochoa-Ricoux JP, Olshevskiy A, Orchanian M, Pahlka RB, Paley J, Pan HR, Park J, Patterson RB, Patton S, Pawloski G, Pec V, Peng JC, Perch A, Pfützner MM, Phan DD, Phan-Budd S, Pinsky L, Plunkett RK, Poonthottathil N, Pun CS, Qi FZ, Qi M, Qian X, Qiu X, Radovic A, Raper N, Rebel B, Ren J, Rosenfeld C, Rosero R, Roskovec B, Ruan XC, Rubin HA, Sail P, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Moed Sher S, Sousa A, Steiner H, Sun GX, Sun JL, Tagg N, Talaga RL, Tang W, Taychenachev D, Thomas J, Thomson MA, Tian X, Timmons A, Todd J, Tognini SC, Toner R, Torretta D, Treskov K, Tsang KV, Tull CE, Tzanakos G, Urheim J, Vahle P, Viaux N, Viren B, Vorobel V, Wang CH, Wang M, Wang NY, Wang RG, Wang W, Wang X, Wang YF, Wang Z, Wang ZM, Webb RC, Weber A, Wei HY, Wen LJ, Whisnant K, White C, Whitehead L, Whitehead LH, Wise T, Wojcicki SG, Wong HL, Wong SC, Worcester E, Wu CH, Wu Q, Wu WJ, Xia DM, Xia JK, Xing ZZ, Xu JL, Xu JY, Xu Y, Xue T, Yang CG, Yang H, Yang L, Yang MS, Yang MT, Ye M, Ye Z, Yeh M, Young BL, Yu ZY, Zeng S, Zhan L, Zhang C, Zhang HH, Zhang JW, Zhang QM, Zhang XT, Zhang YM, Zhang YX, Zhang ZJ, Zhang ZP, Zhang ZY, Zhao J, Zhao QW, Zhao YB, Zhong WL, Zhou L, Zhou N, Zhuang HL, Zou JH; Daya Bay Collaboration; MINOS Collaboration.

Phys Rev Lett. 2016 Oct 7;117(15):151801. Epub 2016 Oct 7. Erratum in: Phys Rev Lett. 2016 Nov 11;117(20):209901.

PMID:
27768356
40.

Search for Sterile Neutrinos Mixing with Muon Neutrinos in MINOS.

Adamson P, Anghel I, Aurisano A, Barr G, Bishai M, Blake A, Bock GJ, Bogert D, Cao SV, Carroll TJ, Castromonte CM, Chen R, Childress S, Coelho JA, Corwin L, Cronin-Hennessy D, de Jong JK, De Rijck S, Devan AV, Devenish NE, Diwan MV, Escobar CO, Evans JJ, Falk E, Feldman GJ, Flanagan W, Frohne MV, Gabrielyan M, Gallagher HR, Germani S, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hahn SR, Hartnell J, Hatcher R, Holin A, Huang J, Hylen J, Irwin GM, Isvan Z, James C, Jensen D, Kafka T, Kasahara SM, Koizumi G, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield PJ, Lucas P, Mann WA, Marshak ML, Mayer N, McGivern C, Medeiros MM, Mehdiyev R, Meier JR, Messier MD, Miller WH, Mishra SR, Moed Sher S, Moore CD, Mualem L, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, O'Connor J, Orchanian M, Pahlka RB, Paley J, Patterson RB, Pawloski G, Perch A, Pfützner MM, Phan DD, Phan-Budd S, Plunkett RK, Poonthottathil N, Qiu X, Radovic A, Rebel B, Rosenfeld C, Rubin HA, Sail P, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga RL, Thomas J, Thomson MA, Tian X, Timmons A, Todd J, Tognini SC, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Whitehead LH, Wojcicki SG, Zwaska R; MINOS Collaboration.

Phys Rev Lett. 2016 Oct 7;117(15):151803. Epub 2016 Oct 7.

PMID:
27768323
42.

H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.

Nichol JN, Dupéré-Richer D, Ezponda T, Licht JD, Miller WH Jr.

Adv Cancer Res. 2016;131:59-95. doi: 10.1016/bs.acr.2016.05.001. Epub 2016 Jun 17. Review.

43.

From Solo in the Silo to Strategic Training Programs.

Koritzinsky M, Koch CA, Riley B, Beauchemin N, Johnston G, Johnston M, Koropatnick J, Loiselle CG, Maslowska M, McCormick C, Miller WH Jr, Mulligan L, Tsao MS.

CBE Life Sci Educ. 2016 Spring;15(1):le1. No abstract available.

44.

"Pigmentary incontinence" in the skin of the nasal plane from normal dogs?

Scott DW, Miller WH Jr.

Vet Dermatol. 2016 Aug;27(4):323-4. doi: 10.1111/vde.12307. Epub 2016 Jun 9. No abstract available.

PMID:
27279542
45.

Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors.

Dupéré-Richer D, Kinal M, Pettersson F, Emond A, Calvo-Vidal MN, Nichol JN, Guilbert C, Plourde D, Klein Oros K, Nielsen TH, Ezponda T, Licht JD, Johnson NA, Assouline S, Cerchietti L, Miller WH Jr, Mann KK.

Leuk Lymphoma. 2017 Jan;58(1):218-221. Epub 2016 May 17. No abstract available.

PMID:
27185211
46.

First Measurement of Electron Neutrino Appearance in NOvA.

Adamson P, Ader C, Andrews M, Anfimov N, Anghel I, Arms K, Arrieta-Diaz E, Aurisano A, Ayres DS, Backhouse C, Baird M, Bambah BA, Bays K, Bernstein R, Betancourt M, Bhatnagar V, Bhuyan B, Bian J, Biery K, Blackburn T, Bocean V, Bogert D, Bolshakova A, Bowden M, Bower C, Broemmelsiek D, Bromberg C, Brunetti G, Bu X, Butkevich A, Capista D, Catano-Mur E, Chase TR, Childress S, Choudhary BC, Chowdhury B, Coan TE, Coelho JA, Colo M, Cooper J, Corwin L, Cronin-Hennessy D, Cunningham A, Davies GS, Davies JP, Del Tutto M, Derwent PF, Deepthi KN, Demuth D, Desai S, Deuerling G, Devan A, Dey J, Dharmapalan R, Ding P, Dixon S, Djurcic Z, Dukes EC, Duyang H, Ehrlich R, Feldman GJ, Felt N, Fenyves EJ, Flumerfelt E, Foulkes S, Frank MJ, Freeman W, Gabrielyan M, Gallagher HR, Gebhard M, Ghosh T, Gilbert W, Giri A, Goadhouse S, Gomes RA, Goodenough L, Goodman MC, Grichine V, Grossman N, Group R, Grudzinski J, Guarino V, Guo B, Habig A, Handler T, Hartnell J, Hatcher R, Hatzikoutelis A, Heller K, Howcroft C, Huang J, Huang X, Hylen J, Ishitsuka M, Jediny F, Jensen C, Jensen D, Johnson C, Jostlein H, Kafka GK, Kamyshkov Y, Kasahara SM, Kasetti S, Kephart K, Koizumi G, Kotelnikov S, Kourbanis I, Krahn Z, Kravtsov V, Kreymer A, Kulenberg Ch, Kumar A, Kutnink T, Kwarciancy R, Kwong J, Lang K, Lee A, Lee WM, Lee K, Lein S, Liu J, Lokajicek M, Lozier J, Lu Q, Lucas P, Luchuk S, Lukens P, Lukhanin G, Magill S, Maan K, Mann WA, Marshak ML, Martens M, Martincik J, Mason P, Matera K, Mathis M, Matveev V, Mayer N, McCluskey E, Mehdiyev R, Merritt H, Messier MD, Meyer H, Miao T, Michael D, Mikheyev SP, Miller WH, Mishra SR, Mohanta R, Moren A, Mualem L, Muether M, Mufson S, Musser J, Newman HB, Nelson JK, Niner E, Norman A, Nowak J, Oksuzian Y, Olshevskiy A, Oliver J, Olson T, Paley J, Pandey P, Para A, Patterson RB, Pawloski G, Pearson N, Perevalov D, Pershey D, Peterson E, Petti R, Phan-Budd S, Piccoli L, Pla-Dalmau A, Plunkett RK, Poling R, Potukuchi B, Psihas F, Pushka D, Qiu X, Raddatz N, Radovic A, Rameika RA, Ray R, Rebel B, Rechenmacher R, Reed B, Reilly R, Rocco D, Rodkin D, Ruddick K, Rusack R, Ryabov V, Sachdev K, Sahijpal S, Sahoo H, Samoylov O, Sanchez MC, Saoulidou N, Schlabach P, Schneps J, Schroeter R, Sepulveda-Quiroz J, Shanahan P, Sherwood B, Sheshukov A, Singh J, Singh V, Smith A, Smith D, Smolik J, Solomey N, Sotnikov A, Sousa A, Soustruznik K, Stenkin Y, Strait M, Suter L, Talaga RL, Tamsett MC, Tariq S, Tas P, Tesarek RJ, Thayyullathil RB, Thomsen K, Tian X, Tognini SC, Toner R, Trevor J, Tzanakos G, Urheim J, Vahle P, Valerio L, Vinton L, Vrba T, Waldron AV, Wang B, Wang Z, Weber A, Wehmann A, Whittington D, Wilcer N, Wildberger R, Wildman D, Williams K, Wojcicki SG, Wood K, Xiao M, Xin T, Yadav N, Yang S, Zadorozhnyy S, Zalesak J, Zamorano B, Zhao A, Zirnstein J, Zwaska R; NOvA Collaboration.

Phys Rev Lett. 2016 Apr 15;116(15):151806. doi: 10.1103/PhysRevLett.116.151806. Epub 2016 Apr 13.

47.

NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.

Nichol JN, Galbraith MD, Kleinman CL, Espinosa JM, Miller WH Jr.

Cell Rep. 2016 Mar 29;14(12):2938-49. doi: 10.1016/j.celrep.2016.02.074. Epub 2016 Mar 17.

48.
49.

Clindamycin for first-time or recurrent canine staphylococcal pyoderma.

Scott DW, Miller WH Jr.

Vet Dermatol. 2016 Feb;27(1):62-3. doi: 10.1111/vde.12275. Epub 2015 Nov 24. No abstract available.

PMID:
26597349
50.

A Symmetrical Quasi-Classical Spin-Mapping Model for the Electronic Degrees of Freedom in Non-Adiabatic Processes.

Cotton SJ, Miller WH.

J Phys Chem A. 2015 Dec 17;119(50):12138-45. doi: 10.1021/acs.jpca.5b05906. Epub 2015 Aug 31.

PMID:
26299361

Supplemental Content

Loading ...
Support Center